Judge Finds Warner-Lambert Accupril Patent Enabled

Law360, New York (December 3, 2007, 12:00 AM EST) -- A federal judge has ruled that claims of the patent involved in a long-standing dispute between Warner-Lambert Co. and generic maker Teva Pharmaceuticals USA Inc. are enabled, rejecting Teva’s theory of invalidity.

Following a bench trial on the matter in May, Judge Dickinson R. Debevoise of the U.S. District Court for the District of New Jersey ruled Thursday that claims in Warner-Lambert’s U.S. Patent Number 4,743,450 were enabled, despite Teva’s arguments that the patent’s vast claims and lack of guidance resulted in a failure to meet...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.